title: Good glycemic control with flexibility in timing of basal insulin supply: a 24-week comparison of insulin glargine given once daily in the morning or at bedtime in combination with morning glimepiride.
authors.affiliation: Munich Diabetes Research Institute, 3 Medical Department, Krankenhaus München-Schwabing, Kölner Platz 1, D-80804, Münich, Germany. eberhard.standl@lrz.uni-muenchen.de
authors.forename: Eberhard
authors.initials: E
authors.lastname: Standl
authors.forename: Stephan
authors.initials: S
authors.lastname: Maxeiner
authors.forename: Sotirios
authors.initials: S
authors.lastname: Raptis
authors.forename: Zahra
authors.initials: Z
authors.lastname: Karimi-Anderesi
authors.forename: Matthias Axel
authors.initials: MA
authors.lastname: Schweitzer
mesh_terms: D001786:Blood Glucose / Q000187:drug effects*; D004359:Drug Therapy, Combination; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced / Q000453:epidemiology; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015994:Incidence; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting; D008875:Middle Aged; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D049528:Insulin, Long-Acting; D013453:Sulfonylurea Compounds; D000069036:Insulin Glargine; C057619:glimepiride